Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Today's Low | Today's High | |
---|---|---|
760.00 764.00 |
| 849.90 839.75 |
52 Week Low | 52 Week High | |
---|---|---|
474.10 (13-Mar-2024) 475.10 (13-Mar-2024) |
| 1,198.25 (06-Nov-2024) 1,197.00 (06-Nov-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
65 | 0 |
Bid Price | Quantity |
---|---|
768.90 | 65.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 65 |
Ask Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Market Cap: | 16.45 Cr |
PE Ratio (TTM): | 26.91 |
PB Ratio: | 3.50 |
Industry P/E: | 28.37 |
Debt to Equity: | - |
ROE: | 13.00 |
EPS (TTM): | 29.34 |
Book Value: | 197.17 |
Face Value: | 5.00 |
Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
---|---|---|---|---|---|
Revenue | 152.67 Cr | 144.79 Cr | 140.71 Cr | 119.70 Cr | 132.73 Cr |
Profit | 14.03 Cr | 12.07 Cr | 11.45 Cr | 9.19 Cr | 12.21 Cr |
Expense | 137.60 Cr | 131.07 Cr | 128.00 Cr | 109.05 Cr | 119.69 Cr |
Comprehensive income | 14.06 Cr | 11.74 Cr | 11.38 Cr | 9.24 Cr | 12.23 Cr |
EPS | 6.75 | 5.79 | 5.37 | 4.24 | 5.60 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Windlas Biotech Limited | Aug, 2021 Aug, 2021 | Pharmaceuticals Pharmaceuticals | WINDLAS WINDLAS |
Promoters | |
---|---|
62.82% |
Public | |
---|---|
37.18% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
62.82% |
Public | |
---|---|
37.18% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
62.44% |
Public | |
---|---|
37.56% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
62.38% |
Public | |
---|---|
37.62% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
61.22% |
Public | |
---|---|
38.78% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Today's stock performance witnessed a fluctuation from a minimum of 760.00 on the NSE (National Stock Exchange) to a maximum of 849.90. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 764.00 to a high of 839.75.
The stock's performance over the past 52 weeks reveals a low of 474.10 (occurred on 13-Mar-2024) and a high of 1,198.25 (achieved on 06-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 475.10 (on 13-Mar-2024), and the 52-week high is 1,197.00 (on 06-Nov-2024).
The stock's performance over the past 52 weeks reveals a low of 474.10 (occurred on 13-Mar-2024) and a high of 1,198.25 (achieved on 06-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 475.10 (on 13-Mar-2024), and the 52-week high is 1,197.00 (on 06-Nov-2024).
The total volume is 1, and the total traded value is 7.63 ( Lakhs).
The upper circuit limit is 1,002.10, and the lower circuit limit is 668.10.
The market cap is 16.45 Cr, and the PE ratio (TTM) is 28.37.
The PB ratio is 3.98, industry P/E is 28.37 .
ROE is 13.00, EPS is 29.34, book value is 197.17
In Sep 2023, Revenue is 1526720000.00, and Profit is 140310000.00. In Jun 2023, Revenue is 1447860000.00, and Profit is 120660000.00.
The company, Windlas Biotech Limited, was listed in Aug 2021 and belongs to the Pharmaceuticals industry. Its NSE symbol is WINDLAS.
As of latest available update, promoters hold 62.82%, the public holds 37.18%, and Employee Trusts holds 0.00.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.